GENETIC SIGNATURES LIMITED
Ownership & governance
Executives 5Directors 4Avg age 62Avg tenure 3.9y
MH
Maria Julianna Halasz
Chief Executive Officer
Since 2026-03-01Profile →
+8
Executives5
Board of directors4
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Perennial Value Management Ltd. | 13.71 % | 31,146,862 |
| FIL Investment Management (Hong Kong) Ltd. | 8.075 % | 18,341,646 |
| Regal Funds Management Pty Ltd. | 7.515 % | 17,069,045 |
| Mercer Investments (Australia) Ltd. | 7.479 % | 16,988,243 |
| Pengana Capital Ltd. | 4.838 % | 10,988,711 |
Catalog · 2026-07-09
Registry officers9
| Name | Role | Since | Shares |
|---|---|---|---|
| Caroline Waldron | Chairman | 2024-11-19 | - |
| Maria Julianna Halasz | Chief Executive Officer | 2026-03-01 | - |
| Michael Aicher | Chief Operating Officer | 2014-01-01 | - |
| Susanne K. Pedersen | Chief Tech/Sci/R&D Officer | 2025-08-17 | - |
| Anne Lockwood | Director/Board Member | 2024-09-30 | - |
| Jenny Harry | Director/Board Member | 2024-09-30 | - |
| Michael Aicher | Director/Board Member | 2014-01-01 | - |
| Angela Wang | Comptroller/Controller/Auditor | — | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 0.31Range 0.31–0.31Analysts 1
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.